COSMOS Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is June - May.

Millions JPY. Fiscal year is Jun - May.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 16, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021
Market Capitalization	499,479	700,001	502,890	525,081	483,107	603,094
Market Cap Growth	-15.27%	39.20%	-4.23%	8.69%	-19.89%	-1.55%
Enterprise Value	519,353	705,765	495,143	507,058	456,292	562,389
Last Close Price	6302.00	8788.16	6258.96	6484.39	5923.09	7353.20
PE Ratio	15.92	22.60	20.57	22.07	20.86	22.21
Forward PE	15.15	21.94	19.07	21.97	19.33	24.17
PS Ratio	0.47	0.69	0.52	0.63	0.64	0.83
PB Ratio	1.82	2.72	2.17	2.49	2.54	3.54
P/TBV Ratio	1.83	2.72	2.18	2.49	2.54	3.54
P/FCF Ratio	-	-	-	67.33	-	333.02
P/OCF Ratio	-	13.34	9.11	9.65	15.01	21.64
PEG Ratio	2.79	1.92	1.92	1.92	1.92	1.92
EV/Sales Ratio	0.49	0.70	0.51	0.61	0.60	0.77
EV/EBITDA Ratio	8.08	11.27	9.63	10.68	10.16	11.98
EV/EBIT Ratio	12.87	17.47	15.72	16.83	15.31	16.97
EV/FCF Ratio	-	-	-	65.02	-	310.54
Debt / Equity Ratio	0.19	0.19	0.15	0.09	0.05	0.06
Debt / EBITDA Ratio	0.79	0.80	0.66	0.38	0.21	0.22
Debt / FCF Ratio	-	-	-	2.33	-	5.77
Net Debt / Equity Ratio	0.07	-0.03	-0.08	-0.13	-0.15	-0.26
Net Debt / EBITDA Ratio	0.31	-0.11	-0.35	-0.58	-0.62	-0.95
Net Debt / FCF Ratio	-	8.24	28.72	-3.56	2.47	-24.66
Asset Turnover	2.10	2.02	2.15	2.11	2.15	2.20
Inventory Turnover	9.02	8.94	9.49	9.16	9.52	10.19
Quick Ratio	0.14	0.31	0.30	0.29	0.28	0.39
Current Ratio	0.66	0.75	0.72	0.71	0.71	0.78
Return on Equity (ROE)	12.00%	12.67%	11.05%	11.85%	12.83%	17.17%
Return on Assets (ROA)	4.94%	5.04%	4.39%	4.80%	5.29%	6.26%
Return on Invested Capital (ROIC)	10.56%	12.74%	11.52%	12.65%	14.47%	20.14%
Return on Capital Employed (ROCE)	12.70%	13.30%	12.00%	13.20%	14.80%	18.20%
Earnings Yield	6.28%	4.42%	4.86%	4.53%	4.79%	4.50%
FCF Yield	-	-0.12%	-0.13%	1.49%	-2.34%	0.30%
Dividend Yield	1.19%	0.80%	0.96%	0.77%	0.68%	0.48%
Payout Ratio	-	16.01%	19.05%	13.72%	14.11%	8.38%
Buyback Yield / Dilution	-	-0.02%	-0.05%	0.00%	0.00%	0.00%
Total Shareholder Return	1.19%	0.78%	0.91%	0.77%	0.68%	0.48%

Updated Feb 28, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.